Exploring the use of leucine zippers for the generation of a new class of inclusion bodies for pharma and biotechnological applications

BACKGROUND: Inclusion bodies (IBs) are biologically active protein aggregates forming natural nanoparticles with a high stability and a slow-release behavior. Because of their nature, IBs have been explored to be used as biocatalysts, in tissue engineering, and also for human and animal therapies. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Roca-Pinilla, Ramon, Fortuna, Sara, Natalello, Antonino, Sánchez-Chardi, Alejandro, Ami, Diletta, Arís, Anna, Garcia-Fruitós, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650227/
https://www.ncbi.nlm.nih.gov/pubmed/32887587
http://dx.doi.org/10.1186/s12934-020-01425-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650227/
https://www.ncbi.nlm.nih.gov/pubmed/32887587
http://dx.doi.org/10.1186/s12934-020-01425-x

Ejemplares similares